GH Research PLC (NASDAQ:GHRS - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $17.99, but opened at $19.19. GH Research shares last traded at $16.65, with a volume of 157,728 shares.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on GHRS shares. Canaccord Genuity Group lowered their target price on GH Research from $31.00 to $28.00 and set a "buy" rating for the company in a report on Monday, November 18th. HC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research note on Monday, January 27th.
Read Our Latest Stock Analysis on GHRS
GH Research Price Performance
The firm has a market capitalization of $722.18 million, a price-to-earnings ratio of -17.57 and a beta of 0.93. The firm has a 50 day moving average price of $8.93 and a 200-day moving average price of $9.03.
Institutional Investors Weigh In On GH Research
An institutional investor recently raised its position in GH Research stock. RA Capital Management L.P. boosted its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 1.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,686,689 shares of the company's stock after acquiring an additional 85,000 shares during the quarter. RA Capital Management L.P. owned 12.85% of GH Research worth $44,734,000 at the end of the most recent quarter. 56.90% of the stock is owned by hedge funds and other institutional investors.
GH Research Company Profile
(
Get Free Report)
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).
Featured Stories
Before you consider GH Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GH Research wasn't on the list.
While GH Research currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
